AKTIS ONCOLOGY INC
AKTSNASDAQ🏆 #2130 by market capUS Equity
$24.78▲ $0.00 (+0.02%)
Live1h▲ 0.7%
24h▲ 0.0%
7d▲ 9.4%
14d▲ 11.0%
30d▼ 3.1%
1y—
🏦Market Cap
$1.32B
Small Cap
📈Revenue Growth (YoY)
+49.9%
High Growth
📊Gross Margin
-11.6%
Thin
💵FCF Margin
—
⚖️P/S Ratio
137.0x
Expensive
Otter Score
53
Weak
📊
Analyst Ratings
Price
$24.78
Total
8
Raised
0
Lowered
2
Avg PT
$37.50
H / L
$40 / $35
| Institution | Action | Rating | Date |
|---|---|---|---|
JP Morgan | Reiterated | Overweight | 2026-07-14 |
HC Wainwright & Co. | Reiterated | Buy | 2026-06-02 |
Piper Sandler | Downgraded | Overweight → Neutral | 2024-01-04 |
B. Riley Securities | Downgraded | Buy → Neutral | 2023-09-07 |
Oppenheimer | Reiterated | Outperform | 2023-09-07 |
Roth MKM | Reiterated | Buy | 2023-05-09 |
Roth Capital | Reiterated | Buy | 2021-05-04 |
Northland Capital Markets | Reiterated | Market Perform | 2019-12-20 |
One row per institution, most recent rating